Innoscripta Shareholders Approve Dividend and Strengthen Governance with Capital Markets Expertise
Innoscripta SE shareholders approved a €4.00 per share dividend and re-elected a supervisory board with strong capital markets experience, positioning the company for international growth and operational efficiency.
Shareholders of innoscripta SE approved a dividend of EUR 4.00 per share for the 2025 financial year at the company's Annual General Meeting, with all agenda items adopted by a strong majority exceeding 97.6%. The meeting also saw the re-election of three supervisory board members whose combined expertise in capital markets, finance, and international corporate development strengthens the company's governance structure.
Philipp von Ilberg, Stefan Berndt-von Bülow, and Dr. Erik Massmann were re-elected to the Supervisory Board, bringing substantial experience from prominent roles. Von Ilberg serves as Chairman of the Supervisory Board of CompuGroup SE & Co. KGaA and has extensive background in complex corporate and capital markets transactions. Berndt-von Bülow offers CFO experience from listed technology companies, including leading a NASDAQ IPO. Massmann, most recently CFO of the Birkenstock Group, was responsible for its NYSE IPO and numerous international finance projects. This board composition is designed to support innoscripta's capital markets strategy and further international expansion.
Shareholders additionally approved the relocation of the company's registered seat from Munich to Tutzing, a move already implemented to enhance organizational structure. Key central functions are now bundled at the new headquarters, while operational units remain in Munich, Cologne, and Frankfurt. This restructuring aims to improve group efficiency, provide fiscal benefits, and create a foundation for growth in international markets. The full voting results from the meeting, where 91.7% of share capital was represented, are available in the Investors section of the company's website: https://www.innoscripta.com/en/investoren/hauptversammlung-2026.
The decisions underscore innoscripta's commitment to shareholder returns through the dividend and strategic governance through the supervisory board appointments. The relocation and board expertise collectively position the company to leverage capital markets opportunities and drive international growth, reflecting a proactive approach to corporate development and operational optimization in a competitive business environment.